C07K 14/72
For hormones
Official title: for hormones {(for neuromediators C07K14/70571)}
C07K14/72 (For hormones) appears on 1,427 US grants and 1,888 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,427
- Published applications
- 1,888
- Assignees
- 820
- Inventors
- 3,684
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 9 | 0 |
| 1994 | 11 | 0 |
| 1995 | 14 | 0 |
| 1996 | 29 | 0 |
| 1997 | 46 | 0 |
| 1998 | 59 | 0 |
| 1999 | 78 | 0 |
| 2000 | 58 | 0 |
| 2001 | 62 | 13 |
| 2002 | 69 | 113 |
| 2003 | 47 | 207 |
| 2004 | 39 | 127 |
| 2005 | 31 | 103 |
| 2006 | 64 | 92 |
| 2007 | 60 | 60 |
| 2008 | 53 | 54 |
| 2009 | 39 | 73 |
| 2010 | 47 | 60 |
| 2011 | 44 | 57 |
| 2012 | 49 | 43 |
| 2013 | 30 | 55 |
| 2014 | 37 | 43 |
| 2015 | 25 | 54 |
| 2016 | 30 | 52 |
| 2017 | 30 | 74 |
| 2018 | 44 | 64 |
| 2019 | 51 | 92 |
| 2020 | 55 | 77 |
| 2021 | 47 | 63 |
| 2022 | 35 | 85 |
| 2023 | 31 | 55 |
| 2024 | 39 | 72 |
| 2025 | 36 | 66 |
| 2026 | 17 | 34 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Nucleic acids encoding humanized anti-PACAP antibodies29 Sep 2026US 12,747,291 B2H. Lundbeck A.S.
- Monospecific antibodies that antagonize leptin receptor25 Aug 2026US 12,715,927 B2Regeneron Pharmaceuticals, Inc.
- Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers16 Jun 2026US 12,655,178 B2Rhythm Pharmaceuticals, Inc.
- Methods of enhancing stem cell differentiation into beta cells26 May 2026US 12,637,661 B2Vertex Pharmaceuticals Incorporated
- Screening methods using canine T2R receptors and pet food products and compositions identified using the same26 May 2026US 12,638,438 B2Mars, Incorporated
- Chimeric receptors8 Oct 2026US 2026/0306631 A1St. Jude Children?S Research Hospital
- Gene therapy8 Oct 2026US 2026/0308598 A1
- Cells expressing parathyroid hormone 1 receptor and uses thereof24 Sep 2026US 2026/0286293 A1Tithon Biotech Inc.
- Gene therapy17 Sep 2026US 2026/0273103 A1Oxford University Innovation Limited
- Synthetic estrogen receptor (er)-derived peptide17 Sep 2026US 2026/0274922 A1The Texas A&M University System
Most cited
By later US patents
- Hormone receptor-related bioassays234US 5,071,773 AThe Salk Institute for Biological Studies · 1991
- Methods of producing nucleic acid ligands204US 5,595,877 ANeXstar Pharmaceuticals, Inc. · 1997
- Nucleic acid ligands to HIV-RT and HIV-1 rev178US 5,496,938 ANeXstar Pharmaceuticals, Inc. · 1996
- Novel receptors for efficient determination of ligands and their antagonists or agonists158US 4,859,609 AGenentech, Inc. · 1989
- Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase152US 5,503,978 AUniversity Research Corporation · 1996